Geftinat 250mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Gefitinib (250mg)
Overview Geftinat 250mg Tablet
Iclusig 250mg tablets treat advanced non-small cell lung cancer. This medication is for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage should strictly follow your physician's instructions, continuing treatment as directed. Treatment length depends on individual response. Your doctor might order regular liver function tests. Common side effects are diarrhea, dry skin, anorexia, and nausea. Increased fluid intake can mitigate side effects. Report any concerning or worsening side effects. Immediately contact your doctor if you experience mouth sores, vision changes, or respiratory problems. Women should use reliable contraception throughout treatment and for one month afterward to prevent pregnancy. Always inform your doctor of all other medications you are currently using.
Uses of Geftinat 250mg Tablet
Lung cancer (excluding small cell types)
Major Benefits of Geftinat 250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Geftinat 250mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Geftinat 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geftinat 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Geftinat tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
How Geftinat 250mg Tablet works:
Iclusig 250mg tablets are a cancer treatment that inhibits the activity of a faulty protein responsible for cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Geftinat 250mg Tablets should not be taken together.
PregnancyCONSULT YOUR DOCTOR
Use of Geftinat 250mg tablets is contraindicated in pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Geftinat 250mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Geftinat 250mg tablets, which can produce adverse effects.
KidneyCAUTION
Iressa 250mg tablets require careful administration for individuals with significant renal impairment. Dosage modification of Iressa 250mg tablets might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of 250mg Geftinat tablets in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary for this population. Physician consultation is advised.
What if you forget to take Geftinat 250mg Tablet :
Omit any missed 250mg Geftinat Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Geftinat 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently